Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Eur J Pharm Biopharm. 2014 May 21;88(2):332–341. doi: 10.1016/j.ejpb.2014.05.012

Figure 7. Measured levels of un-oxidized KGF-2 in the soluble fraction compared with predictions from the model described by Equation 2 and the associated parameters found in Table 5.

Figure 7

Data are for all un-oxidized fractions recorded after storage at 1, 4, 9 and 16 weeks and temperatures of 40, 50, and 60 °C, for each of the formulations.